PD‐1 blocking antibodies moonlighting as killers

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: PD‐1 blocking antibodies moonlighting as killers ; day:18 ; month:05 ; year:2021 ; extent:4
European journal of immunology ; (18.05.2021) (gesamt 4)

Creator: Leitner, Judith
Battin, Claire
Grabmeier‐Pfistershammer, Katharina
Steinberger, Peter

DOI: 10.1002/eji.202149276

URN: urn:nbn:de:101:1-2021051915050086709653

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:01 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Leitner, Judith
Battin, Claire
Grabmeier‐Pfistershammer, Katharina
Steinberger, Peter

Other Objects (12)

Thyrotropin Receptor Blocking Antibodies

The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function

Blocking Plasmodium development in the mosquitoes by human antibodies

Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy

PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy

Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies

Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis

Blocking interaction between SHP2 and PD‐1 denotes a novel opportunity for developing PD‐1 inhibitors

Hochschulschrift

Thyroid blocking antibodies in autoimmune thyroid disease : = Schilddrüsenblockierende Autoantikörper in autoimmuner Schilddrüsenerkrankung

Turning antibodies off and on again using a covalently tethered blocking peptide

Characterization of mixed lymphocyte reaction blocking antibodies (MLR-Bf) in human pregnancy

Blocking the PD-1/PD-L1 axis enhanced cisplatin chemotherapy in osteosarcoma in vitro and in vivo

Thyrotropin Receptor Blocking Antibodies

The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function

Blocking Plasmodium development in the mosquitoes by human antibodies

Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy

PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy

Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies

Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis

Blocking interaction between SHP2 and PD‐1 denotes a novel opportunity for developing PD‐1 inhibitors

Hochschulschrift

Thyroid blocking antibodies in autoimmune thyroid disease : = Schilddrüsenblockierende Autoantikörper in autoimmuner Schilddrüsenerkrankung

Turning antibodies off and on again using a covalently tethered blocking peptide

Characterization of mixed lymphocyte reaction blocking antibodies (MLR-Bf) in human pregnancy

Blocking the PD-1/PD-L1 axis enhanced cisplatin chemotherapy in osteosarcoma in vitro and in vivo

Thyrotropin Receptor Blocking Antibodies

The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function

Blocking Plasmodium development in the mosquitoes by human antibodies

Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy

PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy

Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies

Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis

Blocking interaction between SHP2 and PD‐1 denotes a novel opportunity for developing PD‐1 inhibitors

Hochschulschrift

Thyroid blocking antibodies in autoimmune thyroid disease : = Schilddrüsenblockierende Autoantikörper in autoimmuner Schilddrüsenerkrankung

Turning antibodies off and on again using a covalently tethered blocking peptide

Characterization of mixed lymphocyte reaction blocking antibodies (MLR-Bf) in human pregnancy

Blocking the PD-1/PD-L1 axis enhanced cisplatin chemotherapy in osteosarcoma in vitro and in vivo

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

PD‐1 blocking antibodies moonlighting as killers

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Thyrotropin Receptor Blocking Antibodies

The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function

Blocking Plasmodium development in the mosquitoes by human antibodies

Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy

PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy

Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies

Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis

Blocking interaction between SHP2 and PD‐1 denotes a novel opportunity for developing PD‐1 inhibitors

Thyroid blocking antibodies in autoimmune thyroid disease : = Schilddrüsenblockierende Autoantikörper in autoimmuner Schilddrüsenerkrankung

Turning antibodies off and on again using a covalently tethered blocking peptide

Characterization of mixed lymphocyte reaction blocking antibodies (MLR-Bf) in human pregnancy

Blocking the PD-1/PD-L1 axis enhanced cisplatin chemotherapy in osteosarcoma in vitro and in vivo

Thyrotropin Receptor Blocking Antibodies

The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function

Blocking Plasmodium development in the mosquitoes by human antibodies

Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy

PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy

Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies

Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis

Blocking interaction between SHP2 and PD‐1 denotes a novel opportunity for developing PD‐1 inhibitors

Thyroid blocking antibodies in autoimmune thyroid disease : = Schilddrüsenblockierende Autoantikörper in autoimmuner Schilddrüsenerkrankung

Turning antibodies off and on again using a covalently tethered blocking peptide

Characterization of mixed lymphocyte reaction blocking antibodies (MLR-Bf) in human pregnancy

Blocking the PD-1/PD-L1 axis enhanced cisplatin chemotherapy in osteosarcoma in vitro and in vivo

Thyrotropin Receptor Blocking Antibodies

The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function

Blocking Plasmodium development in the mosquitoes by human antibodies

Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy

PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy

Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies

Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis

Blocking interaction between SHP2 and PD‐1 denotes a novel opportunity for developing PD‐1 inhibitors

Thyroid blocking antibodies in autoimmune thyroid disease : = Schilddrüsenblockierende Autoantikörper in autoimmuner Schilddrüsenerkrankung

Turning antibodies off and on again using a covalently tethered blocking peptide

Characterization of mixed lymphocyte reaction blocking antibodies (MLR-Bf) in human pregnancy

Blocking the PD-1/PD-L1 axis enhanced cisplatin chemotherapy in osteosarcoma in vitro and in vivo

Related objects

Reset password